Optimizing cancer genome sequencing and analysis

Tumors are typically sequenced to depths of 75–100× (exome) or 30–50× (whole genome). We demonstrate that current sequencing paradigms are inadequate for tumors that are impure, aneuploid or clonally heterogeneous. To reassess optimal sequencing strategies, we performed ultra-deep (up to ~312×) whol...

Descripció completa

Guardat en:
Dades bibliogràfiques
Publicat a:Cell Syst
Autors principals: Griffith, Malachi, Miller, Christopher A., Griffith, Obi L., Krysiak, Kilannin, Skidmore, Zachary L., Ramu, Avinash, Walker, Jason R., Dang, Ha X., Trani, Lee, Larson, David E., Demeter, Ryan T., Wendl, Michael C., McMichael, Joshua F., Austin, Rachel E., Magrini, Vincent, McGrath, Sean D., Ly, Amy, Kulkarni, Shashikant, Cordes, Matthew G., Fronick, Catrina C., Fulton, Robert S., Maher, Christopher A., Ding, Li, Klco, Jeffery M., Mardis, Elaine R., Ley, Timothy J., Wilson, Richard K.
Format: Artigo
Idioma:Inglês
Publicat: 2015
Matèries:
Article
Accés en línia:https://ncbi.nlm.nih.gov/pmc/articles/PMC4669575/
https://ncbi.nlm.nih.gov/pubmed/26645048
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.cels.2015.08.015
Etiquetes: Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!

Ítems similars